Introduction {#sec1}
============

Two forms of neurotransmission (NT) occur at fast chemical synapses: evoked NT and the much less studied process of miniature NT. During evoked NT, action potentials trigger the release of multiple synaptic vesicles inducing the synchronous activation of many postsynaptic receptors, thereby allowing information to be transmitted across the synaptic cleft. Evoked NT is absolutely essential to brain function and is considered to be the primary carrier for neurochemical communication between neurons. The second form, miniature NT, often called "minis," occurs via the spontaneous release of single synaptic vesicles from presynaptic neurons activating a small number of postsynaptic receptors. Miniature NT is a general property of every fast chemical synapse studied since their discovery by Katz ([@bib13]). However, in contrast to evoked neurotransmission, the in vivo necessity for miniature events has remained a conundrum and they have been often dismissed as a stochastic byproduct of evoked NT ([@bib31; @bib34; @bib38; @bib50]).

Recent studies, however, have begun to question the notion that miniature events are simply superfluous "noise" derived from the process of evoked NT. First, a number of synaptic vesicle fusion molecules, such as vSNAREs, that are necessary for evoked NT are not essential for miniature NT and vice versa ([@bib22]). Second, specialized synaptic Ca^2+^-sensing molecules can regulate the frequency of miniature events independently of evoked NT ([@bib45]). Third, some evidence suggests that the synaptic vesicle pools that mediate miniature NT and evoked NT may be distinct, though this remains the subject of active debate ([@bib34]). Fourth, though most active zones at *Drosophila* synapses have both forms of NT, some have recently been shown to produce exclusively miniature or evoked events ([@bib29; @bib32]). These studies suggest that miniature events have some properties that are different from evoked NT, prompting the hypothesis that minis could have unique functions at the synapse. Consistent with this idea, in cultured mammalian neurons, miniature NT has been found to influence synaptic scaling, stabilize spine structure, change the activity of postsynaptic kinases, and affect local protein synthesis ([@bib31; @bib38; @bib42]). However, as of yet, an in vivo function for miniature neurotransmission has not been demonstrated.

One in vivo process that can be disrupted by the depletion of both evoked and miniature NT is synaptic structural development. In mammals, the absence of vesicular NT does not appear to disrupt initial pre- and postsynaptic assembly ([@bib44]). Nonetheless, when both forms of NT are depleted at neuromuscular synapses, subsequent aspects of synaptic structural development and maturation are perturbed ([@bib25; @bib46]). However, the individual contribution of evoked or miniature neurotransmission to these phenotypes was not dissected in these studies.

A tractable model to investigate synaptic structural development is *Drosophila* glutamatergic larval neuromuscular junction (NMJ) synapses ([@bib7]). Like synapses in other systems, *Drosophila* terminals undergo a growth and development phase subsequent to initial synaptic assembly. This process involves a 10-fold expansion of the synaptic terminal area through the iterative addition and enlargement of synaptic varicosities or boutons over 4 days of larval development ([@bib36]). Like mammalian synapses, the initial assembly of *Drosophila* terminals is not perturbed when both evoked and miniature neurotransmission are abolished ([@bib8]); however, the effect of a similar depletion on subsequent phases of synaptic development has not been described.

Here, we have investigated the necessity for evoked and miniature neurotransmission during *Drosophila* larval synaptic growth. We found that inhibition of both forms of NT caused characteristic defects in terminal morphology, bouton growth, and ultrastructure. Surprisingly, by manipulating each form of NT independently, we found these defects were caused by the specific loss of miniature NT and not evoked NT. Moreover, we found that increasing miniature NT could promote synaptic growth. We show that miniature NT regulates local synaptic terminal growth by activating a Trio guanine nucleotide exchange factor (GEF), Rac1 GTPase signaling pathway in presynaptic neurons. Our results establish that miniature neurotransmission, an often-overlooked universal feature of all chemical synapses, has a unique and essential role during synaptic development in vivo.

Results {#sec2}
=======

Neurotransmission Is Required for *Drosophila* Larval Synaptic Terminal Development {#sec2.1}
-----------------------------------------------------------------------------------

To determine if neurotransmission is necessary for *Drosophila* larval NMJ synapse development, we sought to inhibit synaptic transmission without perturbing other cellular processes. Vesicular glutamate transporters (Vgluts) are required for the uptake of glutamate into synaptic vesicles ([@bib8]). *Drosophila* has a single *vglut* gene that completely abolishes all NT at glutamatergic NMJ terminals when eliminated. Importantly, removal of Vglut does not impede either exo/endocytosis ([@bib8]), which can disrupt synaptic development independently of effects on NT ([@bib11]). *vglut* null mutants die as embryos, but formation of their synaptic terminals appears normal ([@bib8]). In order to strongly deplete NT during larval stages ([Figure 1](#fig1){ref-type="fig"}H), we combined hypomorphic *vglut* mutants ([@bib8; @bib27]) with transgenic Vglut-RNAi expressed in motor neurons (MNs) to generate *vglut*^MN^. In this mutant combination, the amplitude of evoked excitatory postsynaptic potentials (eEPSPs) was reduced by 66% (p \< 0.001) compared to controls ([Figures 1](#fig1){ref-type="fig"}A and 1B; [Figure S1](#app2){ref-type="sec"}A available online). To determine the total amount of evoked NT, we measured the eEPSP integral ([@bib37]) (normalized area under the eEPSP above the baseline resting membrane potential \[RMP\]) ([Figure 1](#fig1){ref-type="fig"}E). We found that *vglut*^MN^ had a 61% (p \< 0.001) decrease in the eEPSP integral compared to controls ([Figure 1](#fig1){ref-type="fig"}F). We also measured miniature excitatory postsynaptic potential (mEPSP) frequency, amplitude, and the mEPSP integral (normalized average area under the mEPSP above the baseline RMP) ([Figure 1](#fig1){ref-type="fig"}E). In *vglut*^MN^ mutants, we found an 89% reduction (p \< 0.001) in mEPSP frequency ([Figures 1](#fig1){ref-type="fig"}B and [S1](#app2){ref-type="sec"}B) but no change in mEPSP amplitude ([Figures 1](#fig1){ref-type="fig"}B and [S1](#app2){ref-type="sec"}C), consistent with other *vglut* alleles ([@bib8]), leading to an 88% (p \< 0.001) reduction in the mEPSP integral compared to controls ([Figure 1](#fig1){ref-type="fig"}G). Thus, in *vglut*^MN^ mutants, both evoked and miniature NT was inhibited.

When we examined the terminals of *vglut*^MN^ mutants at the third-instar larval stage ([Figure 1](#fig1){ref-type="fig"}H), we found severe morphological defects compared to controls. *vglut*^MN^ mutants had reduced synaptic terminal area ([Figures 1](#fig1){ref-type="fig"}I, 1J, and 1O), but the most striking change we observed was an alteration of individual synaptic bouton sizes ([Figures 1](#fig1){ref-type="fig"}K and 1L). In wild-type third-instar larvae, less than 10% of all synaptic boutons are smaller than 2 μm^2^, while the majority of boutons are larger than this ([Figure S1](#app2){ref-type="sec"}D). In *vglut*^MN^ mutants, we observed a dramatic increase in the proportion of boutons smaller than 2 μm^2^ (small boutons), while the number of synaptic boutons larger than this (typical boutons) in addition to the total number of boutons was reduced compared to controls ([Figure 1](#fig1){ref-type="fig"}P; [Table S1](#app2){ref-type="sec"}). To quantify this shift of bouton sizes, we calculated the ratio of small to typical boutons (bouton size index) and found a 366% (p \< 0.001) increase in *vglut*^MN^ mutants compared to controls ([Figure 1](#fig1){ref-type="fig"}Q). These phenotypes were observed with multiple *vglut* RNAi lines or hypomorphic *vglut* mutants and could be rescued by transgenic Vglut ([Figures S1](#app2){ref-type="sec"}E--S1H). Similar to typical synaptic boutons, the small boutons in *vglut*^MN^ mutants had correctly localized markers for active zones, periactive zones, synaptic vesicles, postsynaptic membranes, and postsynaptic receptor fields ([Figure S2](#app2){ref-type="sec"}A). Therefore, *vglut* mutants have synapses with reduced terminal area concomitant with a disproportionally large amount of small synaptic boutons. This result established that even though synaptic transmission is not required for initial embryonic synapse assembly in *Drosophila* ([@bib8]), it is necessary for the subsequent phase of synaptic terminal growth.

Evoked Neurotransmission Is Not Necessary for Normal Synaptic Terminal Development {#sec2.2}
----------------------------------------------------------------------------------

In *vglut*^MN^ mutants, both evoked and miniature forms of neurotransmission are inhibited. Because the majority of NT at *Drosophila* NMJ terminals is via evoked release ([@bib26]), we next used genetically encoded peptide toxins to specifically block this form of NT and dissect its contribution to synapse development. Transgenic tetanus toxin light chain (UAS-TeTxLC) cleaves the vSNARE n-Synaptobrevin, which is essential for evoked, but not miniature, synaptic vesicle release ([@bib40]). Expression of TeTxLC in a subset of MNs eliminated the ability of these NMJ terminals to produce evoked release when the axon was stimulated ([Figures 1](#fig1){ref-type="fig"}C, 1F, and [S2](#app2){ref-type="sec"}B). In contrast, miniature NT was unaffected ([Figures 1](#fig1){ref-type="fig"}C, 1G, [S2](#app2){ref-type="sec"}C, and S2D). As a second independent method of inhibiting evoked release, we generated a transgenic membrane-tethered version of Plectreurys toxin II (UAS-PLTXII), which blocks the *Drosophila* synaptic N-type voltage-gated calcium channel Cacophony that is essential for evoked release ([@bib47]). Similar to TeTxLC, expression of PLTXII in MNs dramatically reduced evoked release but did not significantly alter miniature NT ([Figures 1](#fig1){ref-type="fig"}D, 1F, 1G, and [S2](#app2){ref-type="sec"}B--S2D). We assessed the effects of expression of both of these toxins on synaptic terminal development ([Figures 1](#fig1){ref-type="fig"}M and 1N). We found no change of synaptic terminal area, the number of synaptic boutons, or the bouton size index at these terminals compared to controls ([Figures 1](#fig1){ref-type="fig"}O--1Q). Therefore, using these criteria, evoked neurotransmission is not required for normal synaptic structural development.

Miniature Neurotransmission Is Required for Synaptic Terminal Development {#sec2.3}
-------------------------------------------------------------------------

Our results indicated that while the inhibition of both evoked and miniature neurotransmission in *vglut*^MN^ mutants perturbed synaptic development, blocking evoked release alone was not detrimental. We therefore hypothesized that miniature NT could be particularly required for synapse development or alternatively that synapse development relied upon the total amount of NT regardless of whether it was derived from evoked or miniature events. To discriminate between these hypotheses, we sought genetic conditions where miniature NT could be preferentially reduced versus evoked NT. To do this, we took advantage of the phenomena of synaptic homeostasis that occurs at both *Drosophila* and mammalian synapses ([@bib9; @bib42]). When postsynaptic ionotropic glutamate receptors (iGluRs) are reduced at *Drosophila* NMJ synapses, presynaptic terminals increase the number of synaptic vesicles released (quantal content) per action potential in order to maintain synaptic strength ([@bib14; @bib33]). We exploited this process in mutant combinations where iGluR function was severely inhibited to specifically reduce miniature NT.

As a starting point, we employed iGluR mutants ([@bib35]) where the expression levels of endogenous glutamate receptor subunits were severely depleted ([Figure S3](#app2){ref-type="sec"}A). In order to avoid disrupting the synaptic scaffolding functions of iGluRs, we combined these mutants with genomic promoter-driven rescuing transgenes. These transgenes produced either a wild-type glutamate receptor subunit (*iGluR*^WT^ combination) or a subunit where the glutamate binding region was mutated ([@bib35]), rendering the receptor nonfunctional (*iGluR*^MUT^ combination) ([Figure S3](#app2){ref-type="sec"}A). Synaptic levels of both *iGluR*^WT^ and *iGluR*^MUT^ receptor clusters were similar when measured using an independent obligate iGluR subunit (dGluRIIC) ([Figures S3](#app2){ref-type="sec"}B--S3D). We then measured NT in these mutants. *iGluR*^WT^ terminals had similar miniature NT to controls ([Figures 2](#fig2){ref-type="fig"}A, 2B, 2F, [S3](#app2){ref-type="sec"}F, and S3G). In contrast, *iGluR*^MUT^ terminals had severely reduced miniature NT with a 96% (p \< 0.001) reduction of the mEPSP integral ([Figures 2](#fig2){ref-type="fig"}C, 2F, [S3](#app2){ref-type="sec"}F, and S3G) compared to controls. Miniature NT defects in *iGluR*^MUT^ mutants were fully rescued by postsynaptic expression of a wild-type iGluR subunit (UAS-dGluR^WT^) ([Figures 2](#fig2){ref-type="fig"}D and 2F). Though both *iGluR*^WT^ and *iGluR*^MUT^ had reduced evoked NT compared to background controls, importantly, they had similar evoked NT to each other ([Figures 2](#fig2){ref-type="fig"}A--2C, 2E, and [S3](#app2){ref-type="sec"}E). As predicted, this was due to an increase in quantal content at *iGluR*^MUT^ terminals compared to *iGluR*^WT^ terminals ([Figure S3](#app2){ref-type="sec"}H). To determine if this homeostatic compensation occurred throughout larval synaptic development, we also measured NT of *iGluR*^WT^ and *iGluR*^MUT^ first-instar larval terminals. Just as in later animals, we found that evoked NT was similar while miniature NT was reduced in *iGluR*^MUT^ mutants compared to *iGluR*^WT^ ([Figures S3](#app2){ref-type="sec"}I--S3N). Therefore, during synaptic development, miniature NT is specifically reduced at *iGluR*^MUT^ terminals compared to *iGluR*^WT^ terminals, while evoked NT remains similar.

We next examined the synaptic terminal morphology of *iGluR*^MUT^ and *iGluR*^WT^ combinations. We found that *iGluR*^MUT^ mutants had aberrant terminals with decreased synaptic terminal area and dramatic 443% increase (p \< 0.001) of the bouton size index ([Figures 2](#fig2){ref-type="fig"}G, 2H, 2J, and 2K) compared to *iGluR*^WT^ terminals. *iGluR*^WT^ terminal morphology was similar to controls ([Figures 2](#fig2){ref-type="fig"}G--2J). The synaptic defects of *iGluR*^MUT^ terminals were strikingly similar to those of *vglut*^MN^ mutants ([Figure 1](#fig1){ref-type="fig"}L) and were rescued by postsynaptic expression of UAS-dGluR^WT^ ([Figures 2](#fig2){ref-type="fig"}G, 2H, and 2L). In addition, though homeostatic compensation was active at *iGluR*^MUT^ terminals, their aberrant morphology was unaltered by the postsynaptic activation or inhibition of the homeostasis regulator CamKII ([Figures S4](#app2){ref-type="sec"}A and S4B) ([@bib15]), indicating these morphological defects were not dependent upon synaptic homeostasis mechanisms. Therefore, the specific synaptic morphology defects of *iGluR*^MUT^ mutants compared to *iGluR*^WT^ supported the hypothesis that miniature events had a unique role in synapse development.

The Role of Miniature Neurotransmission in Synapse Development Is Independent of Evoked Neurotransmission {#sec2.4}
---------------------------------------------------------------------------------------------------------

To further investigate the specific role of miniature neurotransmission in synapse development, we next asked if the phenotypes induced by the loss of miniature events were independent of the amount of evoked NT. To do this, we first blocked evoked release together with miniature NT by MN expression of PLTXII in *iGluR*^MUT^ mutants. This did not further alter miniature NT but, as expected, strongly inhibited evoked release ([Figures 3](#fig3){ref-type="fig"}A--3C, 3G, 3H, and [S4](#app2){ref-type="sec"}D--S4F). In spite of this, the synaptic morphology in these animals was unchanged compared to *iGluR*^MUT^ mutants alone ([Figures 3](#fig3){ref-type="fig"}I--3M). Expression of PLTXII in the MNs of *iGluR*^WT^ also induced no morphological phenotypes (data not shown). Therefore, depleting evoked release in addition to miniature NT did not further disrupt synaptic morphology.

In a converse experiment, we asked if increasing evoked release could compensate for the decreased miniature NT in *iGluR*^MUT^ mutants. Evoked NT, unlike miniature NT, depends upon action potentials, which are induced by voltage-gated sodium channels. To specifically increase evoked NT without affecting miniature NT, we generated a transgenic membrane-tethered version of the Australian funnel-web spider peptide toxin delta-ACTX-Hv1a (UAS-δACTX), which prolongs the activation of the *Drosophila* voltage-gated sodium channel Para by inhibiting its inactivation ([@bib47]). Expression of δACTX in the MNs of control animals increased the amount of evoked NT by prolonging the duration of eEPSPs ([Figure S4](#app2){ref-type="sec"}C). When we expressed δACTX in the MNs of *iGluR*^MUT^ mutants, we also observed prolonged eEPSPs ([Figure 3](#fig3){ref-type="fig"}D) resulting in a 78% (p \< 0.05) increase of evoked NT but no change of miniature NT ([Figures 3](#fig3){ref-type="fig"}G, 3H, and [S4](#app2){ref-type="sec"}D--S4F). Nonetheless, when we examined the synaptic terminals of *iGluR*^MUT^ mutants expressing δACTX, we observed no change of synaptic terminal area or the bouton size index compared to *iGluR*^MUT^ mutants alone ([Figures 3](#fig3){ref-type="fig"}I, 3J, and 3N). This indicated that increasing evoked NT could not rescue synaptic defects induced by the depletion of miniature events. Congruously, we also found no change of synapse morphology when evoked NT was specifically increased or decreased in *vglut* hypomorphic mutants ([Figures S4](#app2){ref-type="sec"}I--S4L). We conclude, therefore, that the role of miniature neurotransmission in synapse development is distinct from and cannot be compensated by evoked release.

Ionotropic Glutamate Receptor Activity Induced by Miniature Events Is Essential for Synapse Development {#sec2.5}
-------------------------------------------------------------------------------------------------------

Presynaptic depletion of vesicular glutamate transporters or postsynaptic disruption of glutamate binding to receptors perturbs synapse morphology. This suggested that the release or detection of glutamate from miniature events was critical for normal synaptic development. To determine if the subsequent ionotropic activity of receptors in response to glutamate was also required, we sought to restore mEPSPs independently of endogenous receptors. To do this, we generated a *Drosophila* transgene of the rat kainate-type ionotropic glutamate receptor subunit GluR6/GRIK2/GluK2 (UAS-rGluK2). This mammalian receptor can form functional homotetrameric channels in heterologous systems ([@bib12; @bib21]). We found that rGluK2 localizes to the *Drosophila* postsynapse when expressed in muscle, though it was not concentrated at active zones unlike endogenous receptors ([Figures S4](#app2){ref-type="sec"}M and S4N). Postsynaptic expression of rGluK2 in control animals did not disrupt synapse morphology (data not shown). When we expressed rGluK2 in the postsynapse of *iGluR*^MUT^ mutants, we found this increased the mEPSP integral \>7-fold (p \< 0.05) compared to *iGluR*^MUT^ mutants alone ([Figures 3](#fig3){ref-type="fig"}E and 3H). The eEPSP integral was also increased, though this did not reach significance ([Figures 3](#fig3){ref-type="fig"}E and 3G). When we examined the synaptic terminals of these animals, we found that the synaptic terminal area was fully restored to control size and the aberrant bouton size index was reduced by 53% (p \< 0.01) ([Figures 3](#fig3){ref-type="fig"}I, 3J, and 3O). This result indicated that ionotropic activity of glutamate receptors was essential for synapse development.

To establish if the rescue ability of rGluK2 specifically depended upon miniature NT, we coexpressed PLTXII in MNs in *iGluR*^MUT^ mutants together with postsynaptic rGlurK2. This combination did not alter miniature NT but strongly reduced evoked release (p \< 0.01) ([Figures 3](#fig3){ref-type="fig"}F--3H) compared to *iGluR*^MUT^ mutants expressing rGluK2 alone. However, the inhibition of evoked NT did not inhibit any aspect of the morphological rescue of *iGluR*^MUT^ mutants by rGluK2 ([Figures 3](#fig3){ref-type="fig"}I, 3J, 3O, and 3P). Expression of PLTXII or rGluK2 in either the pre- or postsynapse of controls did not alter terminal morphology ([Figures S4](#app2){ref-type="sec"}G and S4H; data not shown). This finding further supported a singular requirement for miniature NT in terminal development. We conclude that the ionotropic activity of postsynaptic glutamate receptors, triggered by miniature events, is required for synapse growth.

Increasing Miniature Neurotransmission Promotes Synaptic Terminal Expansion {#sec2.6}
---------------------------------------------------------------------------

Because our results established that reduction of miniature neurotransmission inhibited synaptic development, we next investigated if increasing these events could also change synapse morphology. Complexin proteins bind to neuronal SNARE complexes and regulate neurotransmitter release ([@bib5]). Mutants of *Drosophila* complexin (*cpx*) have a dramatic increase in spontaneous synaptic vesicle release and have increased numbers of synaptic boutons ([@bib17]). We hypothesized that these two phenotypes could be causally related through increased miniature NT. To test this idea, we first measured evoked and miniature NT in *cpx* null mutants. We found no change in the eEPSP integral ([Figures 4](#fig4){ref-type="fig"}A, 4B, and 4H) in these mutants, although eEPSP amplitudes were reduced compared to controls ([Figure S5](#app2){ref-type="sec"}A), consistent with previous studies ([@bib17; @bib18]). In contrast, *cpx* mutants had a dramatic 81-fold increase (p \< 0.001) in miniature NT ([Figures 4](#fig4){ref-type="fig"}A, 4B, and 4I). Expression of a complexin transgene (UAS-Cpx) in MNs rescued *cpx* mutants, restoring miniature NT to control levels ([Figures 4](#fig4){ref-type="fig"}C and 4I). When we measured the terminal morphology of *cpx* mutants, we observed a 44% increase (p \< 0.001) in terminal area ([Figures 4](#fig4){ref-type="fig"}J, 4L, and 4M) accompanied by a 32% increase (p \< 0.001) in typical bouton numbers but a 47% (p \< 0.01) decrease in the number of small boutons ([Figures S5](#app2){ref-type="sec"}B and S5C). This lead to a 64% decrease (p \< 0.001) of the bouton size index ([Figure 4](#fig4){ref-type="fig"}K). As with neurotransmission, rescue of *cpx* mutants with transgenic complexin restored terminal area and the bouton size index ([Figures 4](#fig4){ref-type="fig"}J, 4K, and 4N). Therefore, *cpx* mutants have larger synaptic terminals with a decreased fraction of small boutons, the inverse of *vglut*^MN^ and *iGluR*^MUT^ mutant phenotypes.

We next wished to determine if evoked NT contributed to *cpx* mutant terminal phenotypes. We first analyzed the *cpx*^1257^ mutant allele, which has normal eEPSP amplitudes and kinetics ([@bib18]) ([Figure S5](#app2){ref-type="sec"}A) but has similarly increased miniature NT to *cpx* null alleles ([Figures 4](#fig4){ref-type="fig"}B, 4D, and 4I). We found that *cpx*^1257^ mutants had increased terminal areas with a decreased bouton size index not significantly different from *cpx* null alleles ([Figures 4](#fig4){ref-type="fig"}J, 4K, and 4O). This indicated that the aberrant terminal overgrowth of *cpx* mutants was not due to abnormal evoked release. As a second test, we expressed PLTXII in MNs of *cpx* null mutants. As expected, this strongly inhibited evoked NT without significantly altering miniature events ([Figures 4](#fig4){ref-type="fig"}E, 4H, and 4I). When we measured the terminal morphology of these animals, we found no change compared to *cpx* mutants alone ([Figures 4](#fig4){ref-type="fig"}J, 4K, and 4P). Therefore, evoked NT is not required for the synaptic overgrowth of *cpx* mutants.

We next asked if increased miniature events are necessary for *cpx* mutant terminal overgrowth. We reduced miniature NT by expressing either a dominant-negative glutamate receptor subunit (UAS-dGluR^DN^) ([@bib35]) in postsynaptic muscles or an RNAi against *vglut* (RNAi-Vglut) in the presynaptic MNs of *cpx* mutants ([Figures 4](#fig4){ref-type="fig"}F and 4G) and controls ([Figures S5](#app2){ref-type="sec"}D and S5E). Both manipulations did not significantly alter evoked NT in *cpx* mutants but did decrease miniature NT ([Figures 4](#fig4){ref-type="fig"}F--4I). In both conditions, we found that the aberrant synaptic terminal area and bouton size indexes of *cpx* mutants were suppressed ([Figures 4](#fig4){ref-type="fig"}J, 4K, 4Q, and 4R). Thus, the inhibition of miniature NT suppressed the terminal overgrowth of *cpx* mutants while the depletion of evoked NT did not. Therefore, increased miniature neurotransmission, as found in *complexin* mutants, is sufficient to promote synaptic terminal growth.

Individual Bouton Expansion Is Bidirectionally Regulated by Miniature Neurotransmission {#sec2.7}
---------------------------------------------------------------------------------------

*cpx* mutants had opposing synaptic morphological changes to *vglut*^MN^ and *iGluR*^MUT^ mutants. This was most apparent in the bidirectional effect upon bouton size, with *vglut*^MN^ and *iGluR*^MUT^ mutants having an increase in the proportion of small boutons and *cpx* mutants oppositely having a decreased fraction of these boutons. During terminal development, new synaptic boutons are added and then expand and may also be eliminated ([@bib24; @bib49]). A defect in one or more of these steps could potentially result in the changes to bouton sizes we observed when miniature NT was altered. We sought therefore to visualize the development of individual synaptic boutons by time-lapse live imaging through the transparent cuticle of intact larvae. To do this, we utilized the LexA binary system to express a membrane-localized GFP in the presynaptic terminals of both control and miniature NT mutants. Beginning 24 hr after hatching, we anesthetized animals every 24 hr for 4 days during larval development and imaged their synaptic terminals, returning them to food media between imaging periods.

Using this technique, we found that new synaptic boutons formed continuously throughout the imaging period in control and NT mutant backgrounds at the same rate ([Figures S6](#app2){ref-type="sec"}A and S6B). In control animals, 94.4% (34/36) of newly formed small boutons (\<2 μm^2^) then became progressively larger over time to become typical-sized boutons (\>2 μm^2^) during the imaging period ([Figures 5](#fig5){ref-type="fig"}A and 5G). This expansion in size was not perturbed by inhibiting evoked NT using TeTxLC ([Figures 5](#fig5){ref-type="fig"}B and 5G). However, in *iGluR*^MUT^ mutants, where miniature NT was reduced, we found that the enlargement of small boutons was severely retarded compared to *iGluR*^WT^ animals ([Figures 5](#fig5){ref-type="fig"}C, 5D, and 5H) and only 19.6% (10/51) of small boutons ever expanded to become typical-sized boutons. In contrast, in *cpx* mutants where miniature NT was increased, the rate of expansion of small boutons to typical boutons was accelerated compared to controls ([Figures 5](#fig5){ref-type="fig"}E, 5F, and 5I). The effect on individual bouton growth of increasing or decreasing miniature NT was similar regardless of whether new boutons formed at early, intermediate, or late stages during the 4-day imaging period ([Figures S6](#app2){ref-type="sec"}C--S6H). Finally, we saw no change in the low frequency of elimination of existing boutons in any NT mutant compared to controls ([Figures S6](#app2){ref-type="sec"}I and S6J). Thus, the enlargement of individual synaptic boutons was stalled when miniature NT was inhibited and conversely was accelerated when miniature NT was increased. This modification of the growth properties of individual boutons by altering miniature NT was consistent with the changes we observed of bouton size indexes. These results established that the growth process of individual synaptic boutons was discretely regulated by miniature neurotransmission.

Synapse Maturation Is Regulated by Miniature Neurotransmission {#sec2.8}
--------------------------------------------------------------

In control animals, ∼95% of all small boutons expand to become larger, and our data demonstrated a failure of this process in the majority of boutons when miniature neurotransmission was depleted. We speculated that this morphological change of boutons could be associated with other important features of synaptic maturation. To investigate this, we first compared the synaptic ultrastructure of small (\<2 μm^2^) and typical boutons (\>2 μm^2^) in wild-type animals. We found that both bouton categories were grossly similar with clearly discernable synaptic hallmarks including mitochondria, presynaptic vesicle clusters, synaptic clefts, and postsynaptic elaborations ([Figures 6](#fig6){ref-type="fig"}A and 6C). However, we found that T-bars, the electron-dense presynaptic specializations required for efficacy of evoked release at *Drosophila* synapses ([@bib23]), were different between the active zones of typical and small boutons. While in typical boutons 69% of active zones had a T-bar present, only 36% of active zones in small boutons had an electron-dense presynaptic structure ([Figure 6](#fig6){ref-type="fig"}E). Furthermore, the structures present at small bouton active zones were primitive, irregularly shaped ([Figures 6](#fig6){ref-type="fig"}A and 6C, insets), and smaller than those at the active zones of typical boutons ([Figures 6](#fig6){ref-type="fig"}F and 6G). These results indicated that synaptic ultrastructure is less developed in small boutons compared to typical boutons in wild-type animals.

We then examined the synaptic ultrastructure in *iGluR*^MUT^ mutant terminals and compared them to controls. We found no ultrastructure differences between the typical boutons of *iGluR*^MUT^ mutants and the typical boutons of controls, including the features of active zones and T-bars ([Figures 6](#fig6){ref-type="fig"}A, 6B, and 6E--6G). However, we found that the numerous small boutons in *iGluR*^MUT^ mutants had immature active-zone features similar to those of small boutons in wild-type animals, including reduced T-bar frequency, rudimentary T-bar structure, and reduced T-bar size ([Figures 6](#fig6){ref-type="fig"}C--6G). These data, combined with live-imaging results, suggest that inhibition of miniature NT interrupts synaptic development resulting in boutons becoming stalled in an immature state, reminiscent of the normally transient small boutons of wild-type animals. These results are consistent with miniature neurotransmission also being necessary for synaptic ultrastructural maturation in addition to morphological expansion.

Miniature Neurotransmission Acts Locally to Regulate Synapse Development {#sec2.9}
------------------------------------------------------------------------

We next sought to establish the nature of the developmental signal induced by miniature neurotransmission. Synaptic structure can be influenced by factors that act locally at the individual terminal level (e.g., synaptic adhesion factors; [@bib10]) or throughout the whole neuron (e.g., transcriptional regulation; [@bib28]). Action potentials and evoked NT affect the entire synaptic terminal. In contrast, we surmised that the effects of miniature NT might be spatially restricted to individual active zones and therefore could act locally to regulate bouton maturation. To test this hypothesis, we examined the synaptic terminals generated by the type Ib motor neuron RP3 ([@bib16]). The single axon of this neuron bifurcates to produce synaptic terminals concurrently on two postsynaptic targets: muscle 6 and muscle 7 ([Figure 7](#fig7){ref-type="fig"}A). The ratio of synaptic boutons produced at each muscle is stereotyped ([@bib10]), and these muscles are not electrically coupled with each other ([@bib43]), facilitating independent manipulation of NT. We used Gal4 drivers expressed either in muscle 6 alone (but not muscle 7) ([Figures 7](#fig7){ref-type="fig"}A and [S7](#app2){ref-type="sec"}A) or in both muscles to dissect if miniature NT signaling acts locally at terminals or throughout the neuron.

Similar to other synapses, reduction of miniature NT by *iGluR*^MUT^ reduced typical bouton numbers ([Figures 7](#fig7){ref-type="fig"}B, 7C, and 7F) and increased the fraction of small boutons ([Figure 7](#fig7){ref-type="fig"}G) at both of the RP3 MN terminals on muscles 6 and 7 compared to controls, though the area of these terminals could not be accurately measured due their complex spatial arrangement. When we overexpressed a wild-type iGluR transgene (UAS- dGluR^WT^) in both postsynaptic muscles of *iGluR*^MUT^ mutants, we restored normal miniature NT at both terminals ([Figure S7](#app2){ref-type="sec"}B). This also fully rescued bouton numbers and the bouton size index at both terminals ([Figures 7](#fig7){ref-type="fig"}D, 7F, and 7G). We next expressed UAS-dGluR^WT^ only in muscle 6 of *iGluR*^MUT^ mutants. This increased miniature NT at muscle 6 terminals without altering NT at muscle 7 ([Figure S7](#app2){ref-type="sec"}B). When we examined the morphology of both terminals, we found that bouton numbers and bouton size were restored at terminals at muscle 6 ([Figures 7](#fig7){ref-type="fig"}E--7G). In contrast, however, the terminals at muscle 7 were not rescued ([Figures 7](#fig7){ref-type="fig"}E--7G). Because both terminals are produced by a single neuron, this result suggested that the effect of reduced miniature NT on synaptic bouton maturation is localized to individual terminals.

In a complementary experiment, we examined the suppression of *cpx* mutants using a similar strategy. *cpx* mutant terminals on both muscles 6 and 7 are expanded and the bouton size index was reduced compared to controls ([Figures 7](#fig7){ref-type="fig"}H, 7I, 7L, and 7M). When we expressed dominant-negative UAS-dGluR^DN^ in both postsynaptic muscles of these mutants, the excessive miniature NT at both terminals was strongly inhibited ([Figure S7](#app2){ref-type="sec"}C). In both terminals, the aberrant number and size ratio of synaptic boutons were also suppressed ([Figures 7](#fig7){ref-type="fig"}J, 7L, and 7M). In contrast, when UAS-dGluR^DN^ was expressed only in muscle 6 of *cpx* mutants, miniature NT, bouton number, and bouton size index were only suppressed at the terminal on this muscle and not at the terminal on muscle 7 ([Figures 7](#fig7){ref-type="fig"}K--7M and [S7](#app2){ref-type="sec"}C). Together, these experiments demonstrated that the effect on synapse maturation of increasing or decreasing miniature neurotransmission is via a mechanism that acts locally at synaptic terminals.

Miniature Neurotransmission Regulates Synapse Maturation through the GEF Trio and the GTPase Rac1 {#sec2.10}
-------------------------------------------------------------------------------------------------

To determine the molecular mechanism through which miniature neurotransmission regulates bouton maturation, we next carried out a candidate mutant screen of molecules that were (1) linked to synapse morphological development and (2) likely to have localized activity at terminals. Among these candidates was Trio, a member of the evolutionarily conserved Dbl homology family of GEFs ([@bib30]). *trio* mutants had previously been reported to have defective synaptic terminal growth ([@bib3]), and Trio has been linked to the local regulation of the neuronal cytoskeleton ([@bib30]). We confirmed that *trio* mutants had reduced numbers of synaptic boutons ([@bib3]) ([Figure S8](#app2){ref-type="sec"}A). We additionally found that *trio* mutants had reduced terminal area accompanied by large increase in the proportion of small boutons ([Figures 8](#fig8){ref-type="fig"}A, 8B, 8D, and 8E) very reminiscent of synaptic terminals when miniature NT is reduced ([Figure 8](#fig8){ref-type="fig"}C). All of these *trio* mutant synaptic phenotypes were fully rescued by presynaptic expression of transgenic Trio (UAS-Trio) ([Figures 8](#fig8){ref-type="fig"}D and 8E). When we examined the ultrastructure of the abundant small boutons in *trio* mutants, we found rudimentary T-bar structures ([Figure 8](#fig8){ref-type="fig"}G) of reduced size similar to those observed in the small boutons of miniature NT mutants ([Figures 8](#fig8){ref-type="fig"}H, [S8](#app2){ref-type="sec"}C, and S8D). However, when we measured miniature NT in these mutants, we found it was unchanged compared to controls ([Figure S8](#app2){ref-type="sec"}E), consistent with previous reports ([@bib3]). This indicated that the synaptic terminal phenotypes in *trio* mutants did not originate from defective NT. However, the similarity of *trio* mutant synaptic morphology phenotypes to miniature NT mutant phenotypes suggested that Trio could be part of a molecular pathway triggered by miniature events.

Pursuing this hypothesis, we next tested the genetic interaction of miniature NT mutants with *trio* mutants. We first examined if Trio is required for the terminal overgrowth and bouton size alteration of *cpx* mutants. Double null mutants of *cpx* and *trio* had similarly increased miniature NT to *cpx* mutants alone ([Figure S8](#app2){ref-type="sec"}F). However, when we examined the morphology of these double-mutant terminals, we found that synaptic terminal area and bouton size ratio were not different from *trio* mutants alone ([Figures 8](#fig8){ref-type="fig"}L--8N). Therefore, *cpx* mutant synaptic overgrowth was completely suppressed by the removal of *trio.* Furthermore, when we examined the terminal area and bouton size index of double mutants of *iGluR*^MUT^ and *trio*, they were also not different from *trio* mutant terminals alone ([Figures S8](#app2){ref-type="sec"}G and S8H). Therefore, *iGluR*^MUT^ phenotypes are not genetically additive with *trio* mutant synaptic phenotypes. These results were consistent with Trio and miniature NT acting in a common molecular pathway regulating bouton development.

Building upon this result, we next examined if overexpression of Trio could rescue the effects of loss of miniature NT. When we overexpressed Trio in the MNs of *iGluR*^MUT^ mutants, we found no alteration of miniature NT compared to these mutants alone ([Figure S8](#app2){ref-type="sec"}E). Nonetheless, when we examined the terminals of these animals, we found the synaptic terminal area was fully rescued to control levels and that the aberrant increased ratio of small boutons was suppressed by 44**%** (p \< 0.001) ([Figures 8](#fig8){ref-type="fig"}O--8Q, 8T, and 8U). Overexpression of Trio in the presynapse of control animals caused a small increase in terminal area but no alteration of the bouton size ratio ([Figures S8](#app2){ref-type="sec"}G and S8H). These results indicated that Trio acted as an essential "downstream" mediator of miniature NT in the regulation of bouton development.

Trio has previously been shown to activate the small GTPase Rac1 to modify the neuronal cytoskeleton ([@bib3; @bib30]). We therefore investigated if Rac1 also mediated the effects of miniature NT on synaptic development. Overexpression of either a transgenic wild-type Rac1 (UAS-Rac1^WT^) or a GEF-independent activated mutant of Rac1 (UAS-Rac1^ACT^) in the presynapse of controls induced a small change of terminal area and increased the bouton size index ([Figures S8](#app2){ref-type="sec"}G and S8H). We then tested if these constructs could rescue the effects of reduced miniature NT. Presynaptic overexpression of UAS-Rac1^WT^ in *iGluR*^MUT^ mutants did not alter either synaptic terminal area or the bouton size index compared to *iGluR*^MUT^ mutants alone ([Figures 8](#fig8){ref-type="fig"}R, 8T, and 8U). However, presynaptic overexpression of UAS-Rac1^ACT^ in *iGluR*^MUT^ mutants fully rescued synaptic terminal area to control levels and reduced the aberrant bouton size index by 55% (p \< 0.001) ([Figures 8](#fig8){ref-type="fig"}S--8U). This was comparable to rescue by presynaptic overexpression of Trio ([Figures 8](#fig8){ref-type="fig"}T and 8U). These results are consistent with Rac1 being activated by Trio in response to miniature NT in order to modulate synaptic development. Our results support a mechanism where miniature neurotransmission acts locally at synaptic terminals through a Trio-Rac1 signaling pathway to modify the synaptic cytoskeleton and promote structural maturation.

Discussion {#sec3}
==========

In vertebrates, initial synaptic assembly appears to occur normally in the absence of all vesicular neurotransmission ([@bib44]), though subsequent aspects of structural development at some synapses are perturbed ([@bib25; @bib46]). Similarly, we have found that depletion of both evoked and miniature NT disrupts *Drosophila* synaptic terminal development, particularly of the size of individual synaptic boutons. Surprisingly, however, we found that the specific abolishment of evoked NT using two different transgenic toxins had no effect on synaptic morphology. In contrast, synaptic development was disrupted when miniature NT was specifically depleted by manipulation of postsynaptic glutamate receptors. These phenotypes could be rescued by wild-type receptors, including mammalian glutamate receptors, but were unaltered by manipulating evoked NT. Oppositely, we found that increasing miniature NT is sufficient to induce synaptic terminal overgrowth. Using live imaging, we observed that enlargement of synaptic boutons is bidirectionally responsive to changes in miniature NT, and we found that this process was coupled with the ultrastructural maturation of synaptic active zones. We determined that miniature NT acts locally at synaptic terminals to regulate bouton maturation via a Trio GEF and Rac1 GTPase molecular signaling pathway. Our data therefore reveal a unique and specific requirement for miniature events in the development of synaptic terminals that is not shared with and cannot be compensated by evoked NT. These results indicate that miniature neurotransmission, often dismissed as superfluous "noise" from evoked release, has essential and independent functions in vivo in the nervous system.

Miniature Neurotransmission Is Uniquely Required for Synapse Development {#sec3.1}
------------------------------------------------------------------------

Our data reveal a surprisingly distinct requirement for miniature NT for normal synaptic development. Like many chemical synapses, the majority of neurotransmitter released at *Drosophila* NMJ terminals is via evoked NT. Not only is the amplitude of eEPSPs approximately 50-fold larger than mEPSPs at this terminal, but also evoked release occurs during endogenous activity as frequent rhythmic bursts ([@bib26]). Despite this, when evoked NT was completely abolished at these terminals, we observed no defects in morphological development, consistent with other studies ([@bib11]). Dissection of miniature NT from evoked release was made possible by exploiting synaptic homeostasis ([@bib9; @bib33]), which we show occurs throughout the development of this terminal when postsynaptic glutamate receptors (iGluRs) are inhibited. Replacement of endogenous iGluRs by mutant subunits resulted in conditions where evoked NT was similar to controls, due to a relative increase in the number of synaptic vesicles released per action potential, but miniature NT was dramatically decreased. In these mutants, where miniature NT is depleted far more severely than in previous reports (e.g., dGluRIIA mutants; [@bib33]; data not shown), synaptic maturation was specifically perturbed. These defects were not reliant upon the activation of synaptic homeostasis because they were unaffected by manipulation of CamKII ([@bib15]). Furthermore, very similar defects in synaptic development occur when presynaptic miniature neurotransmitter release is diminished by *vglut* mutations. Therefore, inhibition of the production or detection of postsynaptic miniature events results in developmental defects consistent with a transsynaptic signal. Moreover, additionally increasing or decreasing evoked release, when miniature NT is depleted, does not further alter synaptic development. In contrast, restoring miniature NT in iGluR mutants with either *Drosophila* or mammalian receptors can rescue normal terminal morphology. These results indicate that it is the discrete contribution of miniature NT rather than the total quantity of vesicular NT that is the critical factor necessary for normal synapse development. Therefore, the role of small miniature events during synapse development is qualitatively rather than quantitatively different from the function of larger evoked events. Miniature neurotransmission thus seems to act as a parallel second layer of synaptic communication with a unique and essential role in promoting normal synaptic structural development.

Synapse Maturation Requires Miniature Neurotransmission {#sec3.2}
-------------------------------------------------------

Depletion of miniature NT results in terminals with aberrantly large numbers of small boutons. Two lines of evidence suggest that these small boutons are stalled in an immature phase of a normal growth process. First, live imaging revealed that when miniature NT is depleted, new boutons form at normal frequency but then fail to subsequently expand, unlike wild-type boutons. Second, small boutons in miniature NT mutants have synapse marker and ultrastructure features that appear identical to the small boutons of wild-type animals. These stalled boutons appear different from the aberrant small "satellite boutons" that occur when endocytosis is disrupted and have different synaptic marker and ultrastructure characteristics to normal boutons ([@bib11]). Therefore, our data support that miniature NT is critical for the normal progression of synaptic maturation. Since miniature NT is also a component of synaptic activity, it is intriguing to speculate that miniature events could contribute activity-dependent synaptic structural plasticity.

Localized Signaling by Miniature Neurotransmission {#sec3.3}
--------------------------------------------------

The discrete effect of altering miniature NT on individual bouton maturation coupled with the spatially restricted nature of these small events suggested a localized signaling activity. This was supported by our demonstration that miniature NT can regulate the development of individual synaptic terminals within a single neuron independently of each other. Interestingly, in cultured mammalian neurons, that activity of miniature NT on synaptic scaling also acts the levels of individual dendritic branches ([@bib39]), consistent with localized molecular signaling induced by miniature events in both paradigms. In *Drosophila*, we have identified Trio and Rac1 as essential components of the miniature NT signaling mechanism. *trio* mutants perturb synapse maturation in a manner similar to loss of miniature events, and activation of Trio or Rac1 can rescue miniature NT mutants. Trio and Rac1 have been implicated in actin dynamics in multiple contexts, including axonal growth cones and synapses ([@bib3; @bib30]), and GTPases can act as spatially confined "switches" inducing local cytoskeletal rearrangements. Interestingly, Trio is also transcriptionally regulated by the synaptotrophic BMP pathway ([@bib3]) offering a potential molecular "node" to integrate local fine-tuning of maturation by miniature NT with global synaptic growth regulation. While our data support that Trio and Rac1 mediate the effects of miniature NT on presynaptic neurons, multiple intercellular signaling molecules can interact with Trio ([@bib30]), requiring further investigation to establish how postsynaptic miniature events interact with this presynaptic pathway.

Discriminating between Miniature and Evoked Neurotransmission {#sec3.4}
-------------------------------------------------------------

Our studies beg the question of how miniature NT can be differentiated from evoked NT. The effects of miniature NT on developing synaptic boutons are both specific and localized. In mammalian cultured neurons, it has been suggested that miniature NT can target populations of postsynaptic receptors spatially separated to those activated by evoked neurotransmitter release ([@bib34]). Consistent with this, it has also been directly observed that subpopulations of active zones at *Drosophila* synapses are specialized for the release of either miniature or evoked events ([@bib29; @bib32]). Therefore, miniature and evoked NT may activate spatially distinct postsynaptic signaling mechanisms. An alternative possibility is that differences in the release kinetics between evoked and miniature NT could allow postsynaptic mechanisms to detect and differentiate between them. For example, local or global Ca^2+^ signaling through voltage-gated Ca^2+^ channels can be distinguished by calmodulin ([@bib41]). Unsynchronized activation of glutamate receptors through miniature events could also trigger downstream signaling mechanisms that are not activated by the synchronized activation of receptors by evoked release.

Reconsideration of Minis {#sec3.5}
------------------------

In the past, miniature events were often dismissed as synaptic epiphenomena related to the requirement for a high fidelity of synaptic vesicle release during evoked NT ([@bib38; @bib50]). Several studies over the last decade, however, have challenged this view. For example, miniature synaptic vesicle release has recently been found to be regulated by specialized Ca^2+^ sensors ([@bib45]). mEPSPs can influence the firing rates of cerebellar interneurons, affect synaptic homeostasis, and at elevated levels trigger spiking of hippocampal neurons ([@bib14; @bib31; @bib38]). In cultured neurons, miniature NT can stabilize spine structure and influence the activity of postsynaptic CamKII and is required for synaptic facilitation ([@bib20; @bib31]). Miniature NT can also alter local protein translation in dendrites and has been recently implicated as a potential mechanism of action of some fast-acting antidepressants ([@bib22; @bib39]). Our data now demonstrate an in vivo role for miniature neurotransmission in the regulation of synapse development. Therefore, miniature events, a universal but often-overlooked feature of all chemical synapses, may be critical for many aspects of brain development and function.

Experimental Procedures {#sec4}
=======================

See also [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

*Drosophila* Stocks {#sec4.1}
-------------------

Motor neuron Gal4 drivers were OK319-Gal4 ([@bib4]), OK6-Gal4 ([@bib1]), or D42-Gal4 ([@bib48]). Muscle Gal4 drivers were G14-Gal4 ([@bib1]), C57-Gal4 ([@bib6]), or H94-Gal4 ([@bib10]). Further details and descriptions of transgenic lines, mutant combinations, and transgenes are described in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Electrophysiology {#sec4.2}
-----------------

Intracellular recordings were performed as previously described ([@bib28]) at physiological Ca^2+^ conditions (1.5 mM). eEPSP and mEPSP amplitudes, frequencies, and integrals were measured using the peak detection feature of the MiniAnalysis program (Synaptosoft). All events were verified manually while blinded to genotype. The amplitude, frequency, and integrals of mEPSPs were calculated from continuous recordings in the absence of stimulation (50--100 s). For animals expressing UAS-δACTX, unstimulated spontaneous multiquantal events occurred (data not shown), so mEPSP amplitude, frequency, and integrals were measured in the presence of tetrodotoxin (TTX) (4 μM final concentration), which did not affect miniature NT in control conditions. In *cpx* mutants, mEPSPs were so frequent that conventional measurements of frequency and amplitude were precluded, and the insect ionotropic glutamate receptor antagonist Philanthatoxin-343 (PhTox, Sigma) ([@bib14]) was employed to establish the RMP baseline (4 μM final concentration).

Immunohistochemistry {#sec4.3}
--------------------

Third-instar larvae of comparable size at the ∼2 hr wandering stage time window were collected, dissected, and stained as previously described ([@bib28]). See [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details of the antibodies employed.

Morphological Analysis {#sec4.4}
----------------------

All morphological analysis was done in maximum projections of z stacks from confocal images (Zeiss) of muscle 4 ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [8](#fig8){ref-type="fig"}) or muscles 6 and 7 ([Figure 7](#fig7){ref-type="fig"}) of segment A3, type Ib terminals only, identified by Dlg staining. All quantifications were performed while blinded to genotype. Synaptic terminal area was measured as the area of HRP-labeled presynaptic membrane surrounded by Dlg using MetaMorph (Molecular Devices). Typical boutons were counted as type Ib synaptic axonal varicosities with a size of \>2 μm^2^. Small boutons were counted as type Ib small (\<2 μm^2^) boutons labeled by Dlg. We restricted our analysis to small boutons that were clearly discernable. This may underestimate the actual number of small boutons, because small boutons partially occluded by surrounding typical boutons were excluded. The bouton size index was calculated by dividing the number of small boutons by the number of typical boutons per terminal.

Time-Lapse Live Imaging {#sec4.5}
-----------------------

Presynaptic motor neurons were labeled with membrane localized LexOp-CD8-GFP expressed by vglut-LexA ([@bib2]) in both control and mutant backgrounds. Only images from animals that survived the entire 4-day imaging procedure were included in analysis. For bouton size expansion in live images, the size of each bouton was measured using the round regional tool of MetaMorph while blinded to genotype. Further details are in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Electron Microscopy {#sec4.6}
-------------------

Electron microscopy and ultrastructure quantification were previously described ([@bib19]). Only type Ib boutons, identified by postsynaptic subsynaptic reticulum structure, were selected for quantification. Small boutons were defined as having the longest axis among serial section \<1.6 μm, based on a 2-dimensional projection area of \<2 μm^2^. All small boutons were identified using serial sections. Frequency of T-bar per active zone was verified by serial section images around the active zone. T-bar size was measured at middle images of serial sections where the T-bar size was largest.

Data Analysis {#sec4.7}
-------------

Statistical significance for all morphological and electrophysiological data were determined using a Kruskal-Wallis test followed by a Dunn's post hoc test when multiple comparisons were required. Otherwise, we employed Mann-Whitney-Wilcoxon test (Instat, GraphPad) except for [Figures 6](#fig6){ref-type="fig"}E and [S6](#app2){ref-type="sec"}J, where Fisher's exact test was used.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S8, and Table S1Document S2. Article plus Supplemental Information
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![Neurotransmission Is Required for Larval Synaptic Terminal Development\
(A--D) Representative traces of eEPSPs (above) and mEPSPs (below) from (A) control (CS), (B) *vglut*^MN^ (*vglut*^Hypo/Df^,*UAS-Vglut-RNAi*^KK^;*D42-Gal4*/*UAS-Vglut-RNAi*^JF^), (C) UAS-TeTxLC (*OK319-Gal4*/*UAS-TeTxLC*), and (D) UAS-PLTXII (*OK6-Gal4*/*+*;*+/UAS-PLTXII*).\
(E) Representation of measurement of eEPSP integral (above) and mEPSPs integral (below).\
(F and G) Quantification of (F) eEPSP integral (n ≥ 6) and (G) mEPSPs integral (n ≥ 9) of the indicated genotypes.\
(H) Schematic of *Drosophila* larval neuromuscular junction synaptic terminal development during the experimental period.\
(I--N) Representative NMJ terminals and individual boutons (K and L, insets of M and N) labeled with the postsynaptic marker Dlg (green) and the neuronal membrane marker horseradish peroxidase (HRP) (red). Arrows indicate small boutons (L).\
(O--Q) Quantification of the morphological features of NMJ synaptic terminals including (O) synaptic terminal area, (P) synaptic bouton number, and (Q) the bouton size index (n ≥ 30) of the indicated genotypes.\
All quantification data are normalized to control (Control \[*vglut*\]; *vglut*^Df/+^); (Control \[toxin\]; CS). Scale is identical in (I), (J), (M), and (N); in (K) and (L); and in the insets of (M) and (N). All error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001. See also [Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}.](gr1){#fig1}

![Miniature Neurotransmission Is Required for Normal Synaptic Terminal Development\
(A--D) Representative traces of eEPSPs (above) and mEPSPs (below and inset) from (A) control (*dglurIIA*^+/−^,*IIB*^Df/−^), (B) *iGluR*^WT^ (*dglurIIA*^Hypo/−^,*IIB*^Df/−^;+/*genomic-dglurIIA*^WT^), (C) *iGluR*^MUT^ (*dglurIIA*^Hypo/−^,*IIB*^Df/−^;+/*genomic-dglurIIA*^E783A^), and (D) *iGluR*^MUT^+UAS-dGluR^WT^ (*dglurIIA*^Hypo/−^,*IIB*^Df/−^,*G14-Gal4*;*UAS-dglurIIA*^WT^/*genomic-dglurIIA*^E783A^).\
(E and F) Quantification of (E) eEPSP integral (n ≥ 8) and (F) mEPSP integral (n ≥ 8).\
(G and H) Quantification of the NMJ (G) synaptic terminal area and (H) bouton size index (n ≥ 22). All quantification data are normalized to control.\
(I--L) Representative NMJ terminals and boutons (inset) labeled with Dlg (green) and HRP (red). Scale is the same in (I)--(L) and in the insets of (I)--(L).\
Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figures S3](#app2){ref-type="sec"} and [S4](#app2){ref-type="sec"}.](gr2){#fig2}

![The Requirement of Miniature Neurotransmission for Synapse Development Is Independent of Evoked Neurotransmission and Requires Ionotropic Glutamate Receptor Activity\
(A--F) Representative traces of eEPSPs (above) and mEPSPs (below and inset) from (A) *iGluR*^WT^ (*dglurIIA*^Hypo/−^*,IIB*^Df/−^;*+*/*genomic-dglurIIA*^WT^), (B) *iGluR*^MUT^ (*dglurIIA*^Hypo/−^,*IIB*^Df/−^;*+*/*genomic-dglurIIA*^E783A^), (C) *iGluR*^MUT^ + UAS-PLTXII (*dglurIIA*^Hypo/−^,*IIB*^Df/−^,*OK319-Gal4*;*UAS-PLTXII*/*genomic-dglurIIA*^E783A^), (D) *iGluR*^MUT^ + UAS-δACTX (*dglurIIA*^Hypo/−^,*IIB*^Df/−^,*OK319-Gal4*;*UAS-δACTX*/*genomic-dglurIIA*^E783A^), (E) *iGluR*^MUT^ + UAS-rGluK2 (*dglurIIA*^Hypo/−^,*IIB*^Df/−^,*G14-Gal4*;*UAS-rGluK2*/*genomic-dglurIIA*^E783A^), and (F) *iGluR*^MUT^ + UAS-rGluK2 + UAS-PLTXII (*dglurIIA*^Hypo/−^,*IIB*^Df/−^,*G14-Gal4*,*OK319-Gal4*;*UAS-rGluK2* /*genomic-dglurIIA*^E783A^,*UAS-PLTXII*).\
(G and H) Quantification of (G) eEPSP integral (n ≥ 8) and (H) mEPSP integral (n ≥ 8).\
(I and J) Quantification of the NMJ (I) synaptic terminal area and (J) bouton size index (n ≥ 27). All quantification data are normalized to control (*iGluR*^WT^).\
(K--P) Representative NMJ terminals and boutons (inset) labeled with Dlg (green) and HRP (red). Scale is the same in (K)--(P) and in the insets of (K)--(P).\
Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S4](#app2){ref-type="sec"}.](gr3){#fig3}

![Increasing Miniature Neurotransmission Promotes Synaptic Terminal Expansion\
(A--G) Representative traces of eEPSPs (above) and mEPSPs (below) from (A) control (*cpx*^Df/+^), (B) *cpx*^−/−^ mutant (*cpx*^Df/−^), (C) *cpx*^−/−^ + UAS-Cpx (*UAS-Cpx/+*;*OK6-Gal4/+*;*cpx*^Df/−^), (D) *cpx*^1257/−^ mutant (*cpx*^Df/1257^), (E) *cpx*^−/−^ + UAS-PLTXII (*UAS-PLTXII*/*OK319-Gal4*;*cpx*^Df/−^), (F) *cpx*^−/−^ + UAS-dGluR^DN^ (*G14-Gal4*/*+*;*cpx*^Df/-^,*UAS-dglurIIA*^E783A^), and (G) *cpx*^−/−^ + Vglut-RNAi (*UAS-Vglut-RNAi*^KK^/*OK6-Gal4*;*cpx*^Df/−^).\
(H and I) Quantification of (H) eEPSP integral (n ≥ 8) and (I) mEPSP integral (n ≥ 11).\
(J and K) Quantification of the NMJ (J) synaptic terminal area and (K) bouton size index (n ≥ 23). All quantification data are normalized to control.\
(L--R) Representative NMJ terminals and boutons (inset) labeled with Dlg (green) and HRP (red). Scale is the same in (L)--(R) and in the insets of (L)--(R).\
Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S5](#app2){ref-type="sec"}.](gr4){#fig4}

![Individual Bouton Expansion Is Bidirectionally Regulated by Miniature Neurotransmission\
(A--F) Representative time-lapse images from live animals of synaptic boutons labeled with membrane tagged GFP at muscles 1 or 9 captured every 24 hr during larval development beginning 24 hr after hatching. Small boutons formed before 0 hr and tracked over the imaging period are indicated by arrowheads. Genotypes (A) control(toxin) (*Vglut-lexA*,*LexOp-CD8-GFP*/*+*), (B) UAS-TeTxLC (*OK319-Gal4/UAS-TeTxLC*;*Vglut-lexA*,*LexOp-CD8-GFP/+*), (C) *iGluR*^WT^ (*dglurIIA*^Hypo/-^,*IIB*^Df/-^;*Vglut-lexA*,*LexOp-CD8-GFP*/*genomic-dglurIIA*^WT^), (D) *iGluR*^MUT^ (*dglurIIA*^Hypo/−^,*IIB*^Df/−^;*Vglut-lexA*,*LexOp-CD8-GFP*/*genomic-dglurIIA*^E783A^), (E) control (*cpx*) (*Vglut-lexA*,*LexOp-CD8-GFP*,*cpx*^Df/+^), and (F) *cpx*^−/−^ mutant (*cpx*^Df/−^,*Vglut-lexA*,*LexOp-CD8-GFP*). Scale is the same for all images.\
(G--I) Quantification of the bouton size expansion during the time-lapse imaging period (n ≥ 35 boutons for G, n ≥ 51 boutons for H, and n ≥ 42 boutons for I, from n ≥ 7 NMJs).\
All data are normalized to initial bouton size. Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S6](#app2){ref-type="sec"}.](gr5){#fig5}

![Synaptic Active-Zone Maturation Is Regulated by Miniature Neurotransmission\
(A and B) Representative micrographs of synaptic boutons (above) and active zones (box above, inset below) from a typical-size bouton of (A) control (CS) and (B) *iGluR*^MUT^ mutants.\
(C and D) Representative micrographs of small boutons from (C) control and (D) *iGluR*^MUT^.\
(E--G) Quantification of (E) the active-zone occurrence, (F) T-bar platform size, and (G) T-bar pedestal size (n ≥ 10). Quantification data are normalized to control (F and G).\
Scale is the same in (A)--(D) and in the insets of (A)--(D). Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗^ p \< 0.01, ^∗∗∗^p \< 0.001.](gr6){#fig6}

![Miniature Neurotransmission Acts Locally to Regulate Bouton Development\
(A) Schematic of the two separate synaptic terminals on muscles 6 and 7 generated by the single motor neuron RP3. Muscle Gal4 lines allow rescue of mutants at either both terminals at muscles 6 and 7 or the terminal at muscle 6 only.\
(B--E and H--K) Representative NMJ terminals at muscles 6 and 7, segment A3, labeled with Dlg (green) and HRP (red) from (B) *iGluR*^WT^, (C) *iGluR*^MUT^, (D) *iGluR*^MUT^ + UAS-dGluR^WT^ (muscles 6 and 7) (*dglurIIA*^Hypo/−^,*IIB*^Df/−^;*C57-Gal4*/*genomic-dglurIIA*^E783A^,*UAS-dglurIIA*^WT^), (E) *iGluR*^MUT^ + UAS-dGluR^WT^ (muscle 6 only) (*dglurIIA*^Hypo/−^,*IIB*^Df/−^;*H94-Gal4,nSyb-Gal80*/*genomic-dglurIIA*^E783A^,*UAS-dglurIIA*^WT^), (H) control(*cpx*) (*cpx*^Df/+^), (I) *cpx*^−/−^ mutant, (J) *cpx*^−/−^ + UAS-dGluR^DN^ (muscles 6 and 7) (*G14-Gal4/+*;*cpx*^Df/−^,*UAS-dglurIIA*^E783A^), and (K) *cpx*^−/−^ + UAS-dGluR^DN^ (muscle 6 only) (*cpx*^Df/−^,*UAS-dglurIIA*^E783A^,*H94-Gal4*,*nSyb-Gal80*).\
(F, G, L, and M) Quantification of the typical bouton number (F and L) and bouton size index (G and M) from terminals at muscles 6 and 7 (n ≥ 32). Statistical comparisons are labeled in black for terminal 6 and green for terminal 7.\
All quantification data are normalized to control. Scale is the same for all images. Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001. See also [Figure S7](#app2){ref-type="sec"}.](gr7){#fig7}

![Miniature Neurotransmission Regulates Bouton Maturation through the GEF Trio and the Small GTPase Rac1\
(A--C) Representative boutons of (A) control (CS), (B) *trio*^*−*/−^ mutant, and (C) *iGluR*^MUT^ mutants.\
(F--H) Representative micrographs of the active zone of small boutons of the indicated genotypes.\
(I--L and O--S) Representative NMJ terminals and boutons (inset) from (I) control (CS), (J) *trio*^*−*/−^ mutant, (K) *cpx*^*−*/−^ mutant, (L) *trio*^*−*/−^ ; *cpx*^*−*/−^ mutants, (O) *iGluR*^WT^, (P) *iGluR*^MUT^, (Q) *iGluR*^MUT^ + UAS-Trio (*dglurIIA*^Hypo/−^*,IIB*^Df/−^*,OK319-Gal4*;*UAS-Trio*/*genomic-dglurIIA*^E783A^), (R) *iGluR*^MUT^ + UAS-Rac1^WT^ (*dglurIIA*^Hypo/−^,*IIB*^Df/−^,*OK319-Gal4*;*UAS-Rac1*^WT^/*genomic-dglurIIA*^E783A^), and (S) *iGluR*^MUT^ + UAS-Rac1^Act^ (*dglurIIA*^Hypo/−^*,IIB*^Df/−^,*OK319-Gal4*;*UAS-Rac1*^V12^/*genomic-dglurIIA*^E783A^).\
(D, E, M, N, T, and U) Quantification of the NMJ (D, M, and T) synaptic terminal area and (E, N, and U) bouton size index (n ≥ 23) of the indicated genotypes normalized to controls (CS for *trio*^*−*/−^ and *trio*^*−*/−^ + UAS-Trio), (*cpx*^Df/+^ for *cpx*^*−*/−^ and *trio*^*−*/−^;*cpx*^*−*/−^ mutants), (*iGluR*^WT^ for *iGluR*^MUT^).\
Scale is the same in (A)--(C), in (F)--(H), in (I)--(S), in the insets of (I)--(L), and in the insets of (O)--(S). Error bars indicate ±SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S8](#app2){ref-type="sec"}.](gr8){#fig8}
